|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
GAAD Medical Research Institute Inc. |
|---|---|
| Information provided by: | GAAD Medical Research Institute Inc. |
| ClinicalTrials.gov Identifier: | NCT00674960 |
Purpose
Pick's disease, also known as Pick disease,or FTD is a rare fronto-temporal neurodegenerative disease. This study will investigate the use of far infrared radiation for the control, management and treatment of Pick's disease.
| Condition | Intervention | Phase |
|---|---|---|
|
Pick Disease of the Brain |
Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength) |
Phase I |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
| Official Title: | Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Management, Control and Treatment of Frontotemporal Dementia (Pick's Disease) |
| Estimated Enrollment: | 5 |
| Study Start Date: | May 2008 |
| Estimated Study Completion Date: | June 2010 |
| Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1: Experimental
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
|
Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.
|
This disorder causes progressive destruction of nerve cells in the brain and causes tau proteins to accumulate into the "Pick bodies" that are a defining characteristic of the disease. Tau proteins are microtubule-associated proteins that are abundant in neurons in the central nervous system and are less common elsewhere.
Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.
It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have FTD.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Canada, Ontario | |
| The Centre for Incurable Diseases | |
| Toronto, Ontario, Canada, M4V 1L5 | |
| Principal Investigator: | Ken Nedd, M.D. | GAAD Medical Research Institute Inc. |
More Information
| Responsible Party: | GAAD Medical Research Institute Inc. ( : Dr. Kwasi Donyina/Founder and President ) |
| Study ID Numbers: | GAAD-FD-CTP1 |
| Study First Received: | May 6, 2008 |
| Last Updated: | January 2, 2009 |
| ClinicalTrials.gov Identifier: | NCT00674960 |
| Health Authority: | Canada: Health Canada |
|
Brain Atrophy, Circumscribed Lobar Circumscribed Lobar Atrophy of the Brain Lobar Atrophy (Brain) |
Pick Disease Pick's Disease Picks Disease of Brain |
|
Pick Disease of the Brain Speech Disorders Frontotemporal dementia Aphasia Central Nervous System Diseases Language Disorders Brain Diseases Aphasia, Primary Progressive Cognition Disorders Signs and Symptoms Delirium, Dementia, Amnestic, Cognitive Disorders |
Mental Disorders Neurologic Manifestations Lobar atrophy of brain Atrophy Primary progressive aphasia Dementia Neurobehavioral Manifestations Pick disease of the brain Delirium Communication Disorders |
|
Nervous System Diseases |
